Skadden: Appeals Court Dismisses Off-label False Claims Act Complaint: Adds to Growing List of Successful Challenges to FCA Actions Against Drug and Device Companies | Practical Law
This Skadden, Arps, Slate, Meagher & Flom LLP memorandum discusses an important ruling for pharmaceutical and medical technology companiesfrom the 11th Circuit Court of Appeals dismissing and off-label False Claims Act complaint.